45 related articles for article (PubMed ID: 36417879)
1. Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms.
Ibarra J; Elbanna YA; Kurylowicz K; Ciboddo M; Greenbaum HS; Arellano NS; Rodriguez D; Evers M; Bock-Hughes A; Liu C; Smith Q; Lutze J; Baumeister J; Kalmer M; Olschok K; Nicholson B; Silva D; Maxwell L; Dowgielewicz J; Rumi E; Pietra D; Casetti IC; Catricala S; Koschmieder S; Gurbuxani S; Schneider RK; Oakes SA; Elf SE
Blood Cancer Discov; 2022 Jul; 3(4):298-315. PubMed ID: 35405004
[TBL] [Abstract][Full Text] [Related]
2. Systems biology surveillance decrypts pathological transcriptome remodeling.
Faustino RS; Wyles SP; Groenendyk J; Michalak M; Terzic A; Perez-Terzic C
BMC Syst Biol; 2015 Jul; 9():36. PubMed ID: 26179794
[TBL] [Abstract][Full Text] [Related]
3. Calreticulin is crucial for calcium homeostasis mediated adaptation and survival of thick ascending limb of Henle's loop cells under osmotic stress.
Bibi A; Agarwal NK; Dihazi GH; Eltoweissy M; Van Nguyen P; Mueller GA; Dihazi H
Int J Biochem Cell Biol; 2011 Aug; 43(8):1187-97. PubMed ID: 21554974
[TBL] [Abstract][Full Text] [Related]
4. Unfolding the complexities of ER chaperones in health and disease: report on the 11th international calreticulin workshop.
Gold L; Williams D; Groenendyk J; Michalak M; Eggleton P
Cell Stress Chaperones; 2015 Nov; 20(6):875-83. PubMed ID: 26395641
[TBL] [Abstract][Full Text] [Related]
5. Calreticulin (CALR) promotes ionophore-induced microneme secretion in Toxoplasma gondii.
Shan Z; Song X; Yang X; Xue Y; Wu Y; Wang X; Liu J; Liu Q
Parasitol Res; 2024 Feb; 123(2):139. PubMed ID: 38381180
[TBL] [Abstract][Full Text] [Related]
6. CALR goes rogue.
Melo-Cardenas J; Crispino JD
Blood; 2023 Feb; 141(8):818-820. PubMed ID: 36821187
[No Abstract] [Full Text] [Related]
7. Noncanonical CALR variants.
Langabeer SE
Am J Clin Pathol; 2024 May; 161(5):519. PubMed ID: 38124547
[No Abstract] [Full Text] [Related]
8. Reply to "Noncanonical CALR variants".
Krishnamurthy K
Am J Clin Pathol; 2024 May; 161(5):520. PubMed ID: 38124540
[No Abstract] [Full Text] [Related]
9. Limited Proteolysis-Mass Spectrometry Reveals Aging-Associated Changes in Cerebrospinal Fluid Protein Abundances and Structures.
Shuken SR; Rutledge J; Iram T; Losada PM; Wilson EN; Andreasson KI; Leib RD; Wyss-Coray T
Nat Aging; 2022 May; 2(5):379-388. PubMed ID: 36741774
[TBL] [Abstract][Full Text] [Related]
10. DiLeu Isobaric Labeling Coupled with Limited Proteolysis Mass Spectrometry for High-Throughput Profiling of Protein Structural Changes in Alzheimer's Disease.
Lu H; Wang B; Liu Y; Wang D; Fields L; Zhang H; Li M; Shi X; Zetterberg H; Li L
Anal Chem; 2023 Jul; 95(26):9746-9753. PubMed ID: 37307028
[TBL] [Abstract][Full Text] [Related]
11. Structural Proteomic Profiling of Cerebrospinal Fluids to Reveal Novel Conformational Biomarkers for Alzheimer's Disease.
Wang B; Zhong X; Fields L; Lu H; Zhu Z; Li L
J Am Soc Mass Spectrom; 2023 Mar; 34(3):459-471. PubMed ID: 36745855
[TBL] [Abstract][Full Text] [Related]
12. Author Correction: Proteome-wide structural changes measured with limited proteolysis-mass spectrometry: an advanced protocol for high-throughput applications.
Malinovska L; Cappelletti V; Kohler D; Piazza I; Tsai TH; Pepelnjak M; Stalder P; Dörig C; Sesterhenn F; Elsässer F; Kralickova L; Beaton N; Reiter L; de Souza N; Vitek O; Picotti P
Nat Protoc; 2023 Jun; 18(6):1979. PubMed ID: 36653529
[No Abstract] [Full Text] [Related]
13. Impact of Calreticulin and Its Mutants on Endoplasmic Reticulum Function in Health and Disease.
Arshad N; Cresswell P
Prog Mol Subcell Biol; 2021; 59():163-180. PubMed ID: 34050866
[TBL] [Abstract][Full Text] [Related]
14. Homozygous calreticulin mutations in patients with myelofibrosis lead to acquired myeloperoxidase deficiency.
Theocharides AP; Lundberg P; Lakkaraju AK; Lysenko V; Myburgh R; Aguzzi A; Skoda RC; Manz MG
Blood; 2016 Jun; 127(25):3253-9. PubMed ID: 27013444
[TBL] [Abstract][Full Text] [Related]
15. Calreticulin mutations in myeloproliferative neoplasms.
Shide K
Int Rev Cell Mol Biol; 2021; 365():179-226. PubMed ID: 34756244
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutations of calreticulin in myeloproliferative neoplasms.
Imai M; Araki M; Komatsu N
Int J Hematol; 2017 Jun; 105(6):743-747. PubMed ID: 28470469
[TBL] [Abstract][Full Text] [Related]
17. The role of calreticulin mutations in myeloproliferative neoplasms.
Araki M; Komatsu N
Int J Hematol; 2020 Feb; 111(2):200-205. PubMed ID: 31848992
[TBL] [Abstract][Full Text] [Related]
18. Calreticulin mutations affect its chaperone function and perturb the glycoproteome.
Schürch PM; Malinovska L; Hleihil M; Losa M; Hofstetter MC; Wildschut MHE; Lysenko V; Lakkaraju AKK; Maat CA; Benke D; Aguzzi A; Wollscheid B; Picotti P; Theocharides APA
Cell Rep; 2022 Nov; 41(8):111689. PubMed ID: 36417879
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
